Kevin M. Takakuwa, MD and Dr. Dustin Sulak evaluate how US medical professionals received their cannabis medicine training in Mary Ann Liebert, Inc.
Genester Wilson-King, MD and Dr. Michael Eisenberg are conducting research on cannabis and sexual health at Stanford University. The survey will provide an opportunity for the general public to participate in cannabis research.
SCC member Kevin M. Takakuwa, MD outlines on the historical impact of cannabis and its relevance to pediatric practice. The article highlights how cannabis may benefit seizure disorders in children and young adults.
During Pride Month, we owe it to history to recall an embarrassing, tragic twist in the relationship between AIDS activism and the medical marijuana movement.
The historical account of Dennis Peron, the medical cannabis and human rights activist who was instrumental in bringing attention to AIDS and changing cannabis policy in California.
Findings suggest that CBD may have therapeutic potential to reduce binge eating and the development of obesity, according to a paper published by Addiction Biology.
On June 19 the House of Representatives voted to add the Blumenauer-McClintock Amendment —which would prevent the Department of Justice from enforcing federal law in states that have legalized adult-use marijuana—to an appropriations bill.
“Medical Cannabis and Cannabinoids” is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing field of medical cannabis and cannabinoids.
Marijuana use is prevalent both in states where it is legal to some degree and in states where it is not. However, evidence suggests that many physicians may be unprepared for this reality.
There’s no official endorsement of medical cannabis for dementia, but with or without scientific data, more and more people are willing to investigate cannabis to treat their loved ones.
By Fred Gardner The International Cannabinoid Research Society (ICRS) has adopted the journal Cannabis and Cannabinoid Research (CCR) as its official publication. Dr. Daniele Piomelli, a pharmacologist at UC Irvine, edits the journal.
The press release from the publisher states that CCR is “extremely excited” by the affiliation. The release does not list clinical among the types of studies the ICRS has been “spearheading,” but does list “misuse potential.”
A note from the publisher of Alternative Therapies in Health and Medicine introduces “the first issue of Beyond CBD, a special supplement.” They’re obviously planning more. The lead article, “The Endocannabinoid System and its Modulation by Cannabidiol (CBD)” by Jamie Corroon, ND, MPH, and Jake F. Felice, ND, LMP is the most thorough and well-written overview we’ve seen.